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Abstract
The specific activation of liposomes for delivery has been explored by enzyme mediated cleavage of a peptide substrate
covalently conjugated to a fusogenic lipid. We have previously shown an elastase sensitive peptide conjugated to 1,2-dioleoyl-
sn-glycero-3-phosphatidylethanolamine (DOPE) could be activated by enzymatic cleavage, triggering liposome-liposome
lipid mixing and fusion with erythrocyte ghosts (Pak et al., Biochim. Biophys. Acta, 1372 (1998) 13^27). Further
optimization of this system has been aimed at obtaining substrate cleavage at or below physiological elastase levels and to
demonstrate triggered delivery to living cells. Therefore a new peptide-lipid, MeO-suc-AAPV-DOPE (N-methoxy-succinyl-
Ala-Ala-Pro-Val-DOPE), has been developed that exhibits greater sensitivity and selectivity for elastase cleavage and
subsequent conversion to DOPE. This peptide-lipid was used with DODAP (dioleoyl dimethylammonium propane, a pH
dependent cationic lipid) in a 1:1 mol ratio with the expectation that endocytosis would lead to a liposome with an overall
positive charge if enzymatic cleavage had occurred. Elastase treated liposomes displayed pH dependent enhancement of
binding, lipid mixing, and delivery of 10 000 MW dextrans, relative to untreated liposomes, when incubated with HL60
human leukemic cells. Heat denatured elastase did not activate DODAP/MeO-suc-AAPV-DOPE liposomes, indicating
enzymatic activity of elastase is necessary. Liposomes bound to ECV304 endothelial cells at physiological pH could be
activated by elastase to deliver an encapsulated fluorescent probe, calcein, into the cell cytoplasm. These results suggest
enzyme substrate peptides linked to a fusogenic lipid may be used to elicit specific delivery from liposomes to cells. ß 1999
Elsevier Science B.V. All rights reserved.
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1. Introduction
A paradox of liposomal delivery vehicles is the
requirement for liposomal membranes that are both
stable and yet capable of undergoing fusion or desta-
bilization at the desired site, so as to elicit delivery of
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the contents of the liposome into the cell. We have
previously described the use of enzymatic cleavage to
trigger liposomal fusion and contents delivery [1].
Although other triggers have been utilized to induce
liposomal fusion or membrane destabilization [2^7],
activation by enzyme cleavage has several advantages
over these methods.
Elevated enzyme activity is associated with numer-
ous pathological conditions. Metastatic cancer cells
display enhanced extracellular activity of several deg-
radative enzymes, such as matrix metalloproteinases
and urokinase-type plasminogen activator (for re-
view see [8]). Elevated enzymatic activity facilitates
the extravasation of these cells from the circulation
and increases their invasive potential. In£ammatory
conditions such as cystic ¢brosis [9^12], rheumatoid
arthritis [13,14], and emphysema [15,16] are accom-
panied by an increase in extracellular elastase activity
due to release of elastase from phagocytic cells. Ele-
vated elastase activity appears to be due, in part, to
an imbalance in the elastase/anti-protease ratio
[9,17,18]. Elastase has also been associated with tu-
mor progression and development [19^21]. The ubiq-
uitous yet speci¢c nature of disease-associated enzy-
matic activity, its localization near or on the
membranes of cells involved in tissue remodeling
[22,23] and its association with several pathologies
provide numerous opportunities for triggering specif-
ic liposomal delivery to desired targets using the ac-
tivity of such enzymes. The triggering event would be
expected to convert the liposome from a relatively
inert state to a fusogenic state and may even trigger
speci¢c binding depending on the design.
The selectivity of liposomal activation can be
modulated by the choice of an enzyme substrate con-
jugated to a fusogenic lipid so that enzymatic cleav-
age releases or unmasks fusogenic lipids. Thus lip-
osomes may be designed for a selected site of
activation and hence liposomal delivery could be tar-
geted. We have chosen to use elastase mediated trig-
gering of liposomal fusion as a model for the general
principle of enzymatically activated delivery via lip-
osomes.
We have previously described the activation of lip-
osomal lipid mixing and fusion by enzyme triggering
[1]. A peptide-lipid consisting of N-Ac-Ala-Ala-, an
elastase sensitive peptide sequence, was conjugated to
the headgroup of DOPE (1,2-dioleoyl-sn-glycero-3-
phosphatidylethanolamine), a known fusogenic lipid.
The fusogenic potential of this peptide-lipid, N-Ac-
AA-DOPE, was limited until enzymatic cleavage of
the peptide regenerated DOPE. Liposomes contain-
ing N-Ac-AA-DOPE could be triggered to lipid mix
with target liposomes and fuse with RBC ghosts.
Although N-Ac-AA-DOPE was capable of demon-
strating the utility of enzyme-triggered fusion, phys-
iological relevance requires greater sensitivity to en-
zyme activation, demonstration of delivery to
nucleated living cells and ultimately the ability to
deliver in the physiological milieu which may include
serum proteins. We chose to address the ¢rst two of
these problems in this report.
First, it is necessary to demonstrate that the choice
of an appropriate peptide can be used to optimize
the cleavage and triggering for the desired target at
physiological levels of the enzyme. Powers et al. [24]
had shown that the peptide sequence MeO-suc-Ala-
Ala-Pro-Val- was highly sensitive to elastase cleav-
age. Therefore we hypothesized that this sequence
when conjugated to DOPE would create a trigger-
able peptide-lipid with greater sensitivity. In this
study a new peptide-lipid, MeO-suc-AAPV-DOPE,
was tested for elastase mediated DOPE generation.
Included in this e¡ort was the introduction of a lipid
that would reduce the surface charge of the liposome
compared to the previous version to enhance inter-
action of the positively charged enzyme, elastase,
with the substrate. A second goal was to demonstrate
delivery to nucleated cells, where at least some deliv-
ery may occur via an endosomal compartment. Lip-
osomes were designed to take advantage of the low
pH in that compartment in a manner that would also
enhance elastase triggering. Here we report a liposo-
mal system that could be shown for the ¢rst time, to
be triggered by physiological levels of elastase to
undergo lipid mixing with and aqueous contents de-
livery to nucleated cells.
2. Materials and methods
2.1. Reagents
Human leukocyte elastase was purchased from
Calbiochem (San Diego, CA, USA). Lipids were pur-
chased from Avanti Polar Lipids (Alabaster, AL,
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USA) and were of 99% or greater purity. Calcein
(s 95% pure), tetramethyl rhodamine dextran
(TMR-dextran), and streptavidin were from Molec-
ular Probes (Eugene, OR, USA). Biotinylated-wheat
germ agglutinin (WGA) was obtained from Pierce
(Rockford, IL, USA). MeO-suc-Ala-Ala-Pro-Val-
OH used for covalent linkage with DOPE was
from Bachem Bioscience (King of Prussia, PA,
USA). RPMI 1640, fetal bovine serum (FBS), and
HBSS (Hanks’ balanced salt solution) were pur-
chased from Life Technologies (Gaithersburg, MD,
USA). Medium 199 was purchased from BioWhit-
taker (Walkersville, MD, USA). 1,3-Dicyclohexyl-
carbodiimide (DCC), 4-dimethylaminopyridine
(DMAP), p-nitrophenol and triethylamine were ob-
tained from Sigma (St. Louis, MO, USA). TMD-8
ion exchange resin was purchased from Aldrich (Mil-
waukee, WI, USA). HPLC-grade solvents, tetrahy-
drofuran (THF), chloroform and methanol were pur-
chased from Baxter (McGaw Park, IL, USA). All
chemicals and solvents were used without further
puri¢cation.
2.2. Cells
HL60 human leukemia and ECV304 human endo-
thelial cells were obtained from ATCC (Rockville,
MD, USA). HL60 cells were passaged as suspension
cultures in RPMI 1640 supplemented with 10% heat
inactivated FBS. Adherent ECV304 cells were grown
in medium 199 supplemented with 10% heat inacti-
vated FBS. Greater than 98% viability was observed
during routine tissue culture.
2.3. Synthesis and characterization of N-methoxy-
succinyl alanine alanine proline valine 1,2-
dioleoyl-sn-glycero-3-phosphatidylethanolamine
(MeO-suc-AAPV-DOPE)
2.3.1. MeO-suc-AAPV-p-nitrophenyl ester
To a solution of MeO-suc-AAPV-H peptide (540
mg, 1.15 mmol) was added 142 mg (1.38 mmol) of p-
nitrophenol, 175 mg (1.38 mmol) of DCC and a cat-
alytic amount (a few crystals) of DMAP in 10 ml of
dry chloroform. The reaction mixture was stirred
overnight under nitrogen atmosphere at room tem-
perature. At this point TLC (thin layer chromatog-
raphy) analysis showed that the reaction had gone to
completion. The precipitate, dicyclohexylurea, from
the reaction mixture was ¢ltered using a G-2 funnel
and the ¢ltrate concentrated under reduced pressure.
The residual material was used in next step without
puri¢cation.
2.3.2. MeO-suc-AAPV-1,2-dioleoyl-sn-glycero-
3-phosphatidylethanolamine
To a solution of p-nitrophenyl ester of MeO-suc-
AAPV-OH (600 mg, 1.01 mmol) was added 604 mg
(0.81 mmol) of 1,2-dioleoyl-sn-glycero-3-phospho-
ethanolamine and 82 mg (113 ml, 0.81 mmol) of tri-
ethylamine in 20 ml of chloroform:tetrahydrofuran
(1:4 v/v). The reaction mixture was stirred under
nitrogen atmosphere at room temperature overnight.
TLC analysis showed that the reaction had gone to
the completion. The reaction mixture was concen-
trated under reduced pressure and passed through
activated TMD-8 ion exchange resin in THF:H2O
(9:1 v/v). The phosphorus positive fractions were
pooled and concentrated to get a residual product.
The residual material was puri¢ed with silica gel col-
umn chromatography (the column was washed with
5% methanol in chloroform, then eluted with chloro-
form:methanol:ammonium hydroxide 65:25:4
v/v/v), giving 915 mg (95% yield on the basis of
DOPE), which on lyophilization gave a white solid.
The lipopeptide molecule tested positive with a mo-
lybdenum reagent and negative with a ninhydrin
reagent. By TLC the lipopeptide gave a single spot
and s 99% purity. The lipopeptide was also charac-
terized by NMR and FAB mass spec analysis. Some
characteristic 1H-NMR signals (300 MHz, CDCl3)
are shown here: d 0.87 (t, 3H, J = 7.15 Hz), 1.27
(40H), 1.56 (4H), 2.0 (8H), 2.23 (t, 4H, J = 7.15
Hz), 5.17 (1H), 5.32 (4H, J = 3.12 Hz). The 31P-
NMR spectrum (121.5 MHz, CDCl3) gave a single
signal. FAB (M) calculated for C62H109N5O15P was
1195.55, and masses of 1196.8 (MH) and 1234.9
(MK) were observed.
2.4. Liposome preparation
Large vesicles were prepared by aliquoting desired
amounts of lipid from chloroform stocks into
13U100 mm pyrex tubes and drying under a nitro-
gen stream. After exposure to high vacuum 4 h
overnight the lipid ¢lm was hydrated in 10 mM
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TES (N-tris[hydroxymethyl]methyl-2-aminoethane-
sulfonic acid), 154 mM NaCl, 0.1 mM EDTA (ethyl-
enediamine tetraacetic acid), pH 7.4. Unless speci¢ed
otherwise, this bu¡er was used for all experiments.
After vortexing, samples were freeze-thawed 8U and
extruded under pressure 10U (Lipex, Vancouver,
BC, Canada) through 0.1 Wm polycarbonate ¢lters
(Nucleopore, Pleasanton, CA, USA). Liposomes
were stored at 4‡C until used.
Fluorescent dextran containing liposomes were
prepared by hydrating the DODAP/MeO-suc-
AAPV-DOPE lipid ¢lm with a 50 mg/ml solution
of 10 000 MW TMR-dextran in TES/NaCl/EDTA
bu¡er. Liposomes were then vortexed, freeze-thawed,
and extruded through 0.1 Wm ¢lters as described
above. To remove unencapsulated dextran the lipo-
some solution was extensively dialyzed with the TES/
NaCl/EDTA bu¡er using a Biodialyser (Sialomed,
Columbia, MD, USA) ¢tted with 50 nm pore size
¢lters. Calcein loaded liposomes were prepared by
hydrating the lipid ¢lm in the presence of bu¡er con-
taining 50 mM calcein. The calcein solution was pH
and osmolarity adjusted prior to preparation of lip-
osomes. Calcein loaded liposomes contained 0.75
mol% N-Rho-PE to monitor liposome binding. After
preparation of large vesicles as described above, cal-
cein loaded liposomes were transferred to a 10 000
MWCO Slide-A-Lyzer (Pierce, Rockford, IL, USA)
and extensively dialyzed with TES/NaCl/EDTA bu¡-
er. The encapsulated volume of these liposomes was
0.8 l/mol of lipid. Sonicated vesicles were prepared
by drying lipid in the same manner as described
above but preparations were vortexed then water
bath sonicated for s 10 min at room temperature.
Lipid concentration was monitored by phosphate as-
say [25]. The size of liposomes was veri¢ed by quasi-
elastic light scattering using a Nicomp submicron
particle sizer (Particle Sizing Systems, Santa Barbara,
CA, USA). Freeze-thaw-extrusion vesicles and soni-
cated vesicles were 70^80 nm and 35^45 nm in diam-
eter, respectively, as determined by number weighted
Gaussian analysis.
2.5. Detection of MeO-suc-AAPV-DOPE cleavage
2.5.1. TLC detection of MeO-suc-AAPV-DOPE
cleavage
100 nmol of MeO-suc-AAPV-DOPE sonicated
vesicles were incubated with 0, 5, or 10 Wg elastase
in 0.4 ml TES/NaCl/EDTA bu¡er, pH 7.4, overnight
at 37‡C. Lipid was extracted by organic phase sepa-
ration [26], dried under N2 stream, and exposed to
vacuum for 4 h. Samples were resuspended in chloro-
form and spotted onto TLC plates. TLC was run
using chloroform:methanol:ammonium hydroxide
(65:25:5), air dried, sprayed with molybdenate
blue, and charred on a hot plate.
2.5.2. 31P-NMR analysis
DODAP/MeO-suc-AAPV-DOPE (1:1 mol ratio)
freeze-thaw-extrusion vesicles were prepared and
treated with or without elastase (0^50 Wg protein/
1000 nmol lipid/4 ml) for 2 h in TES/NaCl/EDTA
bu¡er, pH 7.4, at 37‡C. Liposomes were transferred
to 13U64 mm polyallomer centrifuge tubes (Beck-
man, Palo Alto, CA, USA), and pelleted by ultra-
centrifugation at 149 000Ug for 1 h at 4‡C with a
L5-50E ultracentrifuge (Beckman, Palo Alto, CA,
USA). The liposome pellet (approximately 90% of
the total) was resuspended in 100 Wl TES/NaCl/
EDTA bu¡er, to which 400 Wl of 10% deoxycholate,
100 mM EDTA, 20 mM HEPES, pH 7.4, bu¡er and
200 Wl of deuterium oxide (Cambridge Isotope Lab-
oratories, Woburn, MA, USA) were added. After
transfer to 5 mm NMR tubes samples were moni-
tored at room temperature in a Bruker AC300 spec-
trometer operating at 121.5 MHz, with 110 Ws 90‡
radio frequency pulse for proton decoupling and set
to 2 s interpulse delay to avoid signal saturation.
Sweep width was set at 50 kHz. 1 Hz line broadening
was applied to all spectra. Peaks were identi¢ed by
comparison with standards run under identical con-
ditions.
2.6. Binding and lipid mixing of liposomes to HL60
cells
Lipid mixing was monitored by the N-NBD-PE/N-
Rho-PE resonance energy transfer assay, as de-
scribed [27]. Liposomes were prepared with 0.75
mol% N-NBD-PE and 0.75 mol% N-Rho-PE, which
results in quenching of the N-NBD-PE £uorescence
signal. Membrane fusion results in probe di¡usion
and relief from self-quenching, which is monitored
as an increase in N-NBD-PE £uorescence. DO-
DAP/MeO-suc-AAPV-DOPE (1:1 mol:mol) lipo-
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somes were incubated in TES/NaCl/EDTA bu¡er þ
elastase (5 Wg/100 nmol lipid, 250 WM lipid concen-
tration) for 2 h at 37‡C, pH 7.4. HL60 cells were
washed with TES/NaCl/EDTA bu¡er and incubated
with liposomes (1U106 cells, 10 nmol liposome) in
200 Wl TES/NaCl/EDTA bu¡er. Samples were either
at pH 7.4 or adjusted to pH 5 by the addition of
dilute HCl. All samples were shaken in an Eppendorf
Thermomixer (Brinkmann Instruments, Inc., West-
bury, NY, USA), 700 rpm, for 30 min at 37‡C. There
was no reduction in cell viability following this pro-
cedure, as detected by trypan blue exclusion (unpub-
lished data). Cells were then washed with TES/NaCl/
EDTA bu¡er, pH 7.4, and transferred to Falcon 24
well plates (Becton Dickinson, Lincoln Park, NJ,
USA). Fluorescence was monitored in a Cyto£uor
II multiwell £uorescence plate reader (Perseptive Bio-
systems, Framingham, MA, USA) with a quartz
halogen lamp using 450 nm excitation/530 nm emis-
sion or 560 nm excitation/620 nm emission wave-
lengths for N-NBD-PE or N-Rho-PE £uorescence,
respectively. Liposome binding was determined as
the amount of N-Rho-PE £uorescence associated
with washed cells relative to total £uorescence of lip-
osomes added. This percentage was converted to
number of liposomes bound by multiplying by the
number of liposomes added (assuming all liposomes
were 100 nm in diameter and 105 lipid molecules/0.1
Wm diameter liposome. Therefore 6.02U1010 lipo-
somes of 0.1 Wm diameter were added per sample).
The % £uorescence dequenching (FDQ) was calcu-
lated by the following formula:
F t=Fmax cells3Fo alone=Fmax alone =
13Fo alone=Fmax aloneU100
where Ft = N-NBD-PE £uorescence of liposomes in-
cubated with cells at a given time, Fo alone = initial
N-NBD-PE £uorescence of liposomes only, Fmax cells
and Fmax alone = maximal N-NBD-PE £uorescence of
liposomes incubated either with cells or alone, re-
spectively, as determined by addition of 0.5%
C12E8 detergent. FDQ was assumed to result from
all-or-none lipid mixing of liposomes with cells.
Therefore % FDQ could be converted to number
of liposomes mixed by simple multiplication of the
total. This was done to take into account both the
enhancement of binding and the lipid mixing after
elastase activation.
2.7. DODAP/MeO-suc-AAPV-DOPE
liposome-ECV304 binding, lipid mixing, and
calcein delivery
Liposomes were bound to adherent ECV304 cells
via a biotin-streptavidin linkage. To this end DO-
DAP/MeO-suc-AAPV-DOPE (1:1 mol:mol) lipo-
somes were prepared with 0.3 mol% N-biotinyl cap-
roylamine-PE as well as £uorescent lipid probes or
with encapsulated calcein. ECV304 cells were washed
with HBSS bu¡er and then incubated sequentially at
room temperature with biotin-WGA (20 Wg/ml) and
streptavidin (40 Wg/ml) prepared in HBSS, 30 min/
treatment. Cells were washed after each treatment.
Liposomes were treated with or without elastase as
described above. Certain aliquots of pretreated DO-
DAP/MeO-suc-AAPV-DOPE (1:1 mol/mol) lipo-
somes were freeze-thawed after dialysis and prior to
the addition to cells to release the liposomal con-
tents. Such freeze-thawed liposomes were exposed
to a liquid nitrogen-37‡C water bath for 5 cycles.
The self-quenching of calcein was reduced by ap-
proximately 85% (maximal FDQ determined by de-
tergent solubilization) after freeze-thawing, indicat-
ing the release of encapsulated calcein. In all cases,
50^100 nmol of liposomes were added to con£uent
ECV304 cell monolayers (1U105 cells/well of a 24
well plate) and incubated in HBSS for 30 min at
room temperature to promote N-biotinyl cap-PE
binding to streptavidin. Unbound liposomes were re-
moved by repeated washes. After the ¢nal wash,
fresh HBSS bu¡er was added to all wells and cells
were incubated at 37‡C for given times. Fluorescence
was quantitated as described above.
2.8. Fluorescence microscopy of liposome-cell lipid
mixing and aqueous contents delivery
DODAP/MeO-suc-AAPV-DOPE (1:1 mol/mol)
liposomes were incubated for 2 h at 37‡C without
or with elastase (5 Wg protein/100 nmol lipid). Lipo-
somes containing the £uorescent lipid probes N-
NBD-PE and N-Rho-PE were bound to HL60 in
solution as described above. TMR-dextran loaded
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DODAP/MeO-suc-AAPV-DOPE liposomes (40
nmol) were incubated with 1U105 HL60 cells in
200 Wl TES/NaCl/EDTA bu¡er under pH 5, 37‡C,
conditions for 30 min to induce binding. Calcein
loaded DODAP/MeO-suc-AAPV-DOPE liposomes
were bound to ECV304 cells that had been plated
on glass coverslips by the biotinylated-WGA-strepta-
vidin linkage described above. In some experiments
liposomes were freeze-thawed, as described above,
prior to the addition to cells. Cells were washed
with HBSS to remove unbound liposomes and ob-
served with a Bio-Rad (Hercules, CA, USA) MRC-
1000 laser scanning confocal imaging system
equipped with an Olympus BX50 microscope (Olym-
pus, Lake Success, NY, USA) using an apochromat
60U oil (N.A. 1.40) objective. Calcein £uorescence
was excited with the 488 nm line of a krypton/argon
laser and observed at 522 nm emission. N-Rho-PE
and TMR-dextran £uorescence were observed with
the 568 nm line and observed at 605 nm emission.
Images were frame averaged and false color was ap-
plied. All images within a ¢gure were obtained under
identical conditions of confocal iris width, gain, and
black level. Identical false color look up tables were
also applied to images within a ¢gure. Average £uo-
rescence/cell Wm2 of all cells in an image was deter-
mined with the histogram feature of Bio-Rad Co-
MOS confocal imaging software.
3. Results
3.1. Cleavage of MeO-suc-AAPV-DOPE by elastase
Cleavage by elastase to yield DOPE is necessary
for MeO-suc-AAPV-DOPE to act as a trigger for
liposomal delivery. This was tested by incubating
MeO-suc-AAPV-DOPE sonicated vesicles with or
without elastase overnight at 37‡C, after which lipid
was isolated and analyzed by TLC. Incubation with
either 5 or 10 Wg elastase/100 nmol lipid resulted in
the signi¢cant generation of DOPE (Fig. 1), although
there also appeared to be a slower running phos-
phate positive component that may represent an in-
termediate peptide cleavage product. Only minimal
cleavage of MeO-suc-AAPV-DOPE by proteinase
K was observed at the same concentrations (unpub-
lished data), indicating the tetrapeptide sequence is a
more selective target than the previously studied
N-Ac-AA-dipeptide [1].
The conversion of MeO-suc-AAPV-DOPE to
DOPE was also quantitated by 31P-NMR. Since sub-
sequent experiments employed liposomes containing
both DODAP and MeO-suc-AAPV-DOPE, vesicles
with a 1:1 (mol:mol) ratio of these two components
were prepared by the freeze-thaw-extrusion method
(see Section 2) and incubated at 37‡C for 2 h with
increasing amounts of elastase (0^5 Wg elastase/100
nmol lipid). 31P-NMR analysis demonstrated an elas-
tase concentration dependent cleavage of MeO-suc-
AAPV-DOPE and appearance of DOPE (Fig. 2, sol-
id line). A small shoulder that may represent an in-
complete peptide cleavage product was also observed
near the original peptide-lipid peak (unpublished
data). Treatment with 5 Wg elastase/100 nmol lipid
yielded 20% DOPE. Longer incubation may have led
to further digestion, though multiple lamellae and/or
the surface charge of the liposome may limit the
Fig. 1. Elastase mediated cleavage of MeO-suc-AAPV-DOPE as
detected by TLC. 100 nmol of MeO-suc-AAPV-DOPE soni-
cated vesicles were incubated with 0, 5, or 10 Wg elastase in 0.4
ml bu¡er. After overnight incubation at 37‡C lipid was ex-
tracted and spotted onto TLC plates. Plates were run with a
chloroform:methanol:ammonium hydroxide (65:25:5) solvent
system and visualized by charring. Lane 1: MeO-suc-AAPV-
DOPE only; lane 2: +5 Wg elastase; lane 3: +10 Wg elastase;
lane 4: 20 Wg DOPE.
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ultimate amount digested (see Section 4). The max-
imum exposed peptide-lipid for intact liposomes
would occur with unilamellar vesicles. Assuming
only the outer lea£et peptide-lipid is available for
digestion, the minimal percentage conversion of ex-
posed MeO-suc-AAPV-DOPE to DOPE in the outer
lea£et lipid was 40% in this situation (Fig. 2, dotted
line). If the average number of lamellae were greater
than one, the percentage conversion was even higher.
In fact, the ratio of encapsulated volume to total
lipid would appear to indicate an average of approx-
imately 2.5 lamellae per vesicle for this preparation
(see Section 2) which would indicate that 100% of
available peptide-lipid had been cleaved under these
conditions. The concentration of elastase required to
produce this amount of cleavage (12.5 Wg elastase/ml)
is less than the amount of elastase activity found in
the epithelial lining £uid from patients with cystic
¢brosis [28]. The contents from human neutrophil
granules were also able to cleave MeO-suc-AAPV-
DOPE and generate DOPE (unpublished data).
The number of neutrophils required to observe this
e¡ect was less than that observed in epithelial lining
£uid from cystic ¢brosis patients [28], indicating the
amount of elastase required to cleave MeO-suc-
AAPV-DOPE to DOPE is within concentrations
that are physiologically or therapeutically relevant,
with the caveat that the e¡ect of serum proteins
must still be established.
3.2. Optimum DODAP/MeO-suc-AAPV-DOPE
composition for binding and lipid mixing with
HL60 cells
MeO-suc-AAPV-DOPE containing liposomes were
designed to deliver their contents after binding, en-
docytic internalization, and fusion with and/or dis-
ruption of the endosomal membrane. DODAP was
chosen instead of the previously used DOTAP [1]
because only 20% of the DODAP population is pos-
itively charged at pH 7.4 [29]. This allows a more
Fig. 3. Optimum DODAP/MeO-suc-AAPV-DOPE liposome
composition for elastase activation of binding/lipid mixing with
HL60 cells. DODAP/MeO-suc-AAPV-DOPE liposomes pre-
pared at 1:3, 1:1, or 3:1 (mol/mol) ratios and labeled with 0.75
mol% N-NBD-PE and 0.75 mol% N-Rho-PE were incubated
with or without elastase (5 Wg elastase/100 nmol lipid) for 2 h
at 37‡C. 10 nmol of liposomes were then mixed with 1U106
HL60 cells and incubated for 30 min at 37‡C, pH 5. After
washing twice with 5U volume of TES/NaCl/EDTA bu¡er, pH
7.4, (A) binding and (B) lipid mixing was determined by moni-
toring N-Rho-PE and N-NBD-PE £uorescence, respectively.
Fig. 2. Quantitation of elastase mediated cleavage of MeO-suc-
AAPV-DOPE to DOPE by 31P-NMR. DODAP/MeO-suc-
AAPV-DOPE (1:1 mol/mol) freeze-thaw-extrusion vesicles were
incubated with 0, 0.5, 1, 2, 5 Wg elastase/100 nmol lipid. Sam-
ples were incubated for 2 h at 37‡C, after which liposomes
were pelleted by ultracentrifugation. Liposomes were solubilized
and monitored by 31P-NMR. Solid line: % of total MeO-suc-
AAPV-DOPE converted to DOPE; dotted line: % of expected
MeO-suc-AAPV-DOPE on outer monolayers converted to
DOPE assuming unilamellar vesicles, i.e. result multiplied by 2.
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complete peptide hydrolysis by elastase (unpublished
data, see Section 4) so that we can model the more
general case of cleavage on the liposome surface that
is not a¡ected by the high charge of the enzyme. For
other enzymatic activators it may be possible to uti-
lize a permanently positively charged lipid that
would allow the liposome to become positively
charged at physiological pH after peptide cleavage,
so that extracellular binding would be triggered. By
contrast, the tertiary amine of DODAP would
be fully protonated at pH 5, suggesting liposomes
containing DODAP would undergo stronger inter-
action with negatively charged cell membranes within
the low pH environment of the endocytic compart-
ment.
In order to determine the optimum combination of
DODAP and MeO-suc-AAPV-DOPE for triggerable
binding and lipid mixing with cells the two lipids
were formulated into liposomes at di¡erent ratios.
DODAP/MeO-suc-AAPV-DOPE liposomes pre-
pared at 1:3, 1:1, and 3:1 mol ratios were pretreated
with or without elastase and incubated with HL60
cells under low pH conditions to promote DODAP
mediated binding to cells. Only DODAP/MeO-suc-
AAPV-DOPE liposomes at a 1:1 mol ratio exhibited
an elastase dependent increase in binding and lipid
mixing with HL60 cells (Fig. 3), possibly as a result
of increased positive charge after enzymatic cleavage.
Apparently the amount of DODAP in 1:3 liposomes
was insu⁄cient to mediate binding to cells, even at
pH 5 after elastase treatment. By contrast, DODAP/
MeO-suc-AAPV-DOPE (3:1 mol ratio) liposomes
were able to bind to cells with or without elastase
treatment, re£ecting the greater amount of DODAP
in these liposomes. These liposomes were also able to
lipid mix with cells even without elastase activation.
The DODAP/MeO-suc-AAPV-DOPE 1:1 mol ratio
liposomal formulation was chosen for all further
studies in order to develop a delivery system that
can be triggered by enzymatic cleavage.
3.3. Elastase activated binding and lipid mixing of
DODAP/MeO-suc-AAPV-DOPE liposomes with
HL60 cells
Since DODAP was included in liposomes with
MeO-suc-AAPV-DOPE to enhance binding with
cells under low pH conditions, we determined
whether the pH dependence of DODAP mediated
binding is within physiological levels. DODAP/
MeO-suc-AAPV-DOPE (1:1) liposomes were pre-
treated with elastase and incubated with HL60 cells
at di¡erent pH. Enhanced binding and lipid mixing
of elastase pretreated liposomes with HL60 cells were
observed when incubated at pH 4.6 or pH 5.1 (Fig.
4). Incubation at pH 5.8^7.4 did not yield any sig-
ni¢cant association of liposomes with cells. These
results suggest that these liposomes are sensitive to
elastase mediated activation of binding and lipid
mixing when DODAP is maximally positively
charged. The pH required to achieve this state is
present under normal physiological conditions within
the late endosome [30].
To con¢rm that the enzymatic activity of elastase
Fig. 4. pH dependence of DODAP/MeO-suc-AAPV-DOPE
liposome binding/lipid mixing with HL60 cells. Fluorescent lipid
probe labeled DODAP/MeO-suc-AAPV-DOPE liposomes were
incubated with or without elastase (5 Wg elastase/100 nmol lip-
id) for 2 h at 37‡C. 10 nmol of liposomes were mixed with
1U106 HL60 cells in 200 Wl TES/NaCl/EDTA bu¡er. Samples
were incubated for 30 min at 37‡C, at the given pH and
washed. Binding (A) and lipid mixing (B) were determined by
monitoring N-Rho-PE and N-NBD-PE £uorescence, respec-
tively.
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was responsible for triggering of binding and lipid
mixing, DODAP/MeO-suc-AAPV-DOPE liposomes
were pretreated with heat inactivated elastase. Heat-
ing elastase to 95‡C for 1 h completely abrogated
enzymatic cleavage of either a chromogenic substrate
or MeO-suc-AAPV-DOPE (unpublished data). Pre-
treatment of DODAP/ MeO-suc-AAPV-DOPE lipo-
somes with heat inactivated elastase did not enhance
binding or lipid mixing with HL60 cells above back-
ground levels (Fig. 5). Only active elastase was capa-
ble of triggering the increased association. As ex-
pected, pH 5 conditions were required to observe
this e¡ect, since at pH 7.4 the binding of these lip-
osomes to HL60 cells was greatly reduced. Confocal
microscopy of liposomes with HL60 cells con¢rmed
that elastase pretreatment was required for enhanced
binding and lipid mixing. Bright £uorescent labeled
cells indicate the N-Rho-PE £uorescent probe from
the bound elastase activated liposomes had mixed
into the cell plasma membrane (Fig. 6). In contrast,
untreated liposomes displayed signi¢cantly less bind-
ing and lipid mixing (Fig. 6). Quantitation of £uo-
rescence images revealed nearly 12 times as much
£uorescence/cell area in HL60 cells that had been
incubated with DODAP/MeO-suc-AAPV-DOPE lip-
osomes treated with elastase, as compared to those
cells incubated with untreated liposomes, although
the distribution of this enhanced delivery may not
be uniform across all the cells. Almost no £uores-
cence was associated with the cells at pH 7.4 (unpub-
lished data).
3.4. Aqueous contents delivery from
DODAP/MeO-suc-AAPV-DOPE liposomes to
HL60 cells
To determine if the enhanced lipid mixing between
elastase activated DODAP/MeO-suc-AAPV-DOPE
liposomes and HL60 cells is truly indicative of fu-
sion, it is necessary to monitor the delivery of an
aqueous probe from the liposome to the cell cyto-
plasm. Therefore DODAP/MeO-suc-AAPV-DOPE
liposomes were loaded with tetramethyl rhodamine
labeled 10 000 MW dextran (TMR-dextran), treated
with or without elastase, and incubated with HL60
cells under pH 5 conditions.
Only DODAP/MeO-suc-AAPV-DOPE liposomes
that had been pretreated with elastase were capable
of fusing with HL60 cells, as demonstrated by TMR-
dextran labeling of the cytoplasm of these cells (Fig.
7). HL60 cells incubated with liposomes that had not
been treated with elastase contained little or no cy-
toplasmic £uorescent dextran, indicating elastase
cleavage was required to trigger the fusion of DO-
DAP/MeO-suc-AAPV-DOPE liposomes with HL60
cells. TMR-dextran delivery to cells was not due to
leakage of the £uorescent dextran out of the lipo-
somes and subsequent uptake by HL60 cells. This
possibility was investigated by inducing a TMR-dex-
tran release from DODAP/MeO-suc-AAPV-DOPE
liposomes (with or without elastase pretreatment)
with repeated freeze-thaw cycles after the liposomes
Fig. 5. Active elastase is required for triggering DODAP/MeO-
suc-AAPV-DOPE liposome binding/lipid mixing with HL60
cells. DODAP/MeO-suc-AAPV-DOPE liposomes containing
0.75 mol% N-NBD-PE and 0.75 mol% N-Rho-PE were incu-
bated alone, with elastase (5 Wg elastase/100 nmol lipid), or
with an equivalent amount of heat inactivated elastase (95‡C,
1 h) for 2 h at 37‡C. 10 nmol of pretreated liposomes were
mixed with 1U106 HL60 cells in 200 Wl TES/NaCl/EDTA bu¡-
er. Samples were incubated for 30 min, 37‡C, at either pH 7.4
or pH 5 and washed. Binding (A) and lipid mixing (B) were de-
termined by monitoring N-Rho-PE and N-NBD-PE £uores-
cence, respectively.
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were dialyzed and diluted into a bu¡er. Incubation of
HL60 cells with this mixture of such freeze-thawed
liposomes and free TMR-dextran did not result in
HL60 cell labeling (Fig. 7). Only elastase activated,
intact DODAP/Me-suc-AAPV-DOPE liposomes
loaded with TMR-dextran could fuse and deliver
dextran to cells.
3.5. Elastase activated binding, lipid mixing, and
calcein delivery of DODAP/MeO-suc-AAPV-
DOPE liposomes with adherent ECV304
endothelial cells
Pretreatment of DODAP/MeO-suc-AAPV-DOPE
liposomes with elastase activated these liposomes to
Fig. 6. Confocal microscopy of DODAP/MeO-suc-AAPV-DOPE liposome interaction with HL60 cells. DODAP/MeO-suc-AAPV-
DOPE liposomes labeled with 0.75 mol% N-NBD-PE and 0.75 mol% N-Rho-PE were incubated alone or with elastase (5 Wg elastase/
100 nmol lipid) for 2 h at 37‡C as described in Fig. 5. After washing, cells were observed for N-Rho-PE £uorescence. Color range of
0^255 pixel values (0, bottom; 255, top) is given in upper right corner of each image in Fig. 7.
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bind and fuse with HL60 cells when the pH was
arti¢cially lowered to mimic the endosomal environ-
ment (Fig. 7). We next tested whether a similar e¡ect
could be observed when elastase treated liposomes
were internalized by endocytosis. In order to accom-
plish this it was necessary to bind these liposomes to
cells under physiological conditions at pH 7.4. This
was done via a biotin-streptavidin linkage. We
turned to an adherent cell line, ECV304 endothelial
cells, to circumvent complications arising from bio-
tin-streptavidin mediated aggregation of the suspen-
sion HL60 cells. ECV304 cells were sequentially
treated with biotinylated-WGA- streptavidin. DO-
DAP/MeO-suc-AAPV-DOPE liposomes containing
trace amounts of N-biotinyl cap-PE and pretreated
with or without elastase were then added to the cells
and incubated at pH 7.4. Elastase pretreated lipo-
somes exhibited enhanced binding, as compared to
untreated liposomes (Fig. 8), perhaps as a result of
decreased negative surface charge or better accessi-
bility of the biotinyl group. It appears that in this
case the elastase activation augments the biotin-
streptavidin mediated binding. The biotin-streptavi-
din linkage was required, as the absence of biotin-
streptavidin treatment abrogated any binding of un-
treated or elastase pretreated liposomes at this pH
Fig. 7. Delivery of TMR-dextran from DODAP/MeO-suc-AAPV-DOPE liposomes to HL60 cells. DODAP/MeO-suc-AAPV-DOPE
liposomes loaded with 10 000 MW TMR-dextran were incubated alone or with elastase (5 Wg elastase/100 nmol lipid) for 2 h at 37‡C.
Liposomes were then added directly to cells or subjected to ¢ve freeze-thaw cycles to release encapsulated TMR-dextran. 40 nmol of
intact or freeze-thawed liposomes were mixed with 2U105 HL60 cells and incubated for 30 min at 37‡C, pH 5. After washing, cells
were observed for TMR-dextran £uorescence by confocal microscopy. Color range of 0^255 pixel values (0, bottom; 255, top) is given
in upper right corner of each image.
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(unpublished data). Liposomes with or without elas-
tase activation were localized within perinuclear en-
docytic vesicles (Fig. 10). Despite the enhanced bind-
ing of elastase pretreated liposomes and uptake into
endocytic vesicles there was only a slight increase in
lipid mixing of these liposomes with ECV304 cells
(Fig. 8). This may be due to the nature of the assay.
The £uorescence dequenching assay requires the dif-
fusion of the N-NBD-PE and N-Rho-PE probe after
lipid mixing. Di¡usion of the £uorescent lipid probes
after fusion with the endosomal membrane may be
insu⁄cient to completely diminish the resonance en-
ergy transfer. Therefore an aqueous contents delivery
assay was employed.
DODAP/MeO-suc-AAPV-DOPE liposomes were
loaded with self-quenched concentrations of calcein,
a £uorescent aqueous probe. After extensive dialysis
to remove unencapsulated calcein these liposomes
were pretreated with or without elastase and bound
to ECV304 cells by biotinylated WGA-streptavidin.
Elastase pretreated liposomes displayed relatively
rapid calcein dequenching that increased over the
course of several hours (Fig. 9). Maximal dequench-
ing of calcein appears to be achieved after 2 h at
37‡C, which was consistent with the time course of
DODAP/MeO-suc-AAPV-DOPE liposome endocy-
tosis (unpublished data) and cationic lipid:DNA
complex uptake [31]. The apparent delivery of calcein
was completely dependent upon liposome-cell inter-
actions, as calcein loaded liposomes subjected to
identical conditions of elastase pretreatment and
pH 5 environment but without co-incubation with
cells did not demonstrate any increase in calcein £u-
orescence dequenching (unpublished data). DODAP/
MeO-suc-AAPV-DOPE liposomes that had not been
treated with elastase exhibited much less initial cal-
cein dequenching that slowly increased over time,
albeit not to levels observed with the elastase acti-
vated liposomes (Fig. 9). Repeated freeze-thaw cycles
of DODAP/MeO-suc-AAPV-DOPE liposomes re-
sults in almost complete release of encapsulated cal-
cein. Incubation of this mixture of freeze-thawed lip-
osomes and released free calcein with ECV304 cells
resulted in only 2^3% of the calcein uptake observed
with cells incubated with intact liposomes (unpub-
lished data). This result indicates the £uorescence
dequenching observed with elastase pretreated intact
Fig. 9. Elastase triggered calcein delivery from DODAP/MeO-
suc-AAPV-DOPE liposomes to ECV304 cells at pH 7.4. DO-
DAP/MeO-suc-AAPV-DOPE liposomes loaded with self-
quenched concentration of calcein and N-Rho-PE as a lipid
marker were incubated with or without elastase (5 Wg elastase/
100 nmol lipid) for 2 h at 37‡C. 100 nmol liposomes were
added to ECV304 cells that had been pretreated with biotin-
ylated WGA and streptavidin. After a 30 min incubation at
room temperature the cell monolayer was washed to remove
unbound liposomes and samples were incubated for 0, 1, 2, 4,
or 6 h at 37‡C. At the given times calcein delivery was deter-
mined by monitoring calcein £uorescence.
Fig. 8. Binding/lipid mixing of DODAP/MeO-suc-AAPV-DOPE
liposomes with ECV304 cells at pH 7.4. DODAP/MeO-suc-
AAPV-DOPE liposomes containing N-NBD-PE and N-Rho-PE
were incubated alone or with elastase (5 Wg elastase/100 nmol
lipid) for 2 h at 37‡C. 100 nmol of pretreated liposomes were
added to ECV304 cells that had been pretreated with biotin-
ylated WGA and streptavidin (see Section 2). After a 30 min
incubation at room temperature the cell monolayer was washed
to remove unbound liposomes and samples were incubated for
additional 2 h at 37‡C. Binding and lipid mixing were deter-
mined by monitoring N-Rho-PE and N-NBD-PE £uorescence,
respectively.
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liposomes was due to delivery and not to non-speci¢c
uptake of free calcein.
Confocal microscopy of ECV304 cells incubated
with elastase pretreated DODAP/MeO-suc-AAPV-
DOPE liposomes contained bright £uorescent peri-
nuclear localized vesicles that appear to be due to
the uptake of the calcein loaded liposomes into endo-
somes. Importantly, these cells also had di¡use £uo-
Fig. 10. Confocal microscopy of elastase activated calcein delivery from DODAP/MeO-suc-AAPV-DOPE liposomes to ECV304 cells
at pH 7.4. DODAP/MeO-suc-AAPV-DOPE liposomes loaded with a quenched concentration of calcein were incubated alone or with
elastase (5 Wg elastase/100 nmol lipid) for 2 h at 37‡C. 100 nmol of pretreated intact liposomes were added to ECV304 cells which
had been pretreated with biotinylated WGA and streptavidin. After a 30 min incubation at room temperature the cell monolayer was
washed to remove unbound liposomes and samples were incubated for an additional 4 h at 37‡C. Cells were observed by confocal mi-
croscopy for calcein £uorescence. Color range of 0^255 pixel values (0, bottom; 255, top) is given in upper right corner of each im-
age.
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rescence within the cells (Fig. 10) that is indicative of
calcein delivery into the cytosol. The di¡use £uores-
cence was not due to non-speci¢c uptake of calcein
released from liposomes prior to endocytosis, as
loaded liposomes subjected to freeze-thaw cycles
did not result in £uorescently labeled cells (unpub-
lished data). Unactivated liposomes were also endo-
cytosed into vesicles near the nucleus. However,
there was no di¡use £uorescence visible with these
liposomes. Quantitation of the total £uorescence/
cell area showed ECV304 cells incubated with elas-
tase activated DODAP/MeO-suc-AAPV-DOPE lipo-
somes had more than twice the amount of calcein
£uorescence as those incubated with unactivated lip-
osomes. Without elastase pretreatment there does
not appear to be signi¢cant delivery of the encapsu-
lated calcein into the cell cytoplasm.
4. Discussion
We previously demonstrated that liposomes con-
taining the N-Ac-AA-DOPE peptide-lipid could be
activated to lipid mix with target liposomes and
fuse with RBC ghosts [1]. In this study, enzymati-
cally triggered liposomes have been induced to mix
lipids and fuse with adherent cells. The critical mod-
i¢cations required for increased fusogenicity are the
creation of a new peptide-lipid that exhibits greater
sensitivity and speci¢city for elastase cleavage, and
the reformulation of liposomes with DODAP. This
latter change decreases the initial positive charge and
thereby enhances sensitivity to elastase mediated
cleavage.
Creating a peptide-lipid with increased sensitivity
and selectivity was accomplished by substituting N-
Ac-AA with MeO-suc-AAPV, a highly sensitive sub-
strate for elastase mediated cleavage [24]. Conjuga-
tion of this peptide to DOPE yielded a peptide-lipid
with greatly enhanced susceptibility to elastase cleav-
age (Figs. 1 and 2), relative to N-Ac-AA-DOPE [1].
The increased sensitivity was accompanied by greater
selectivity of cleavage. Proteinase K is a relatively
non-speci¢c protease that was able to cleave the
ala-ala dipeptide from the N-Ac-AA-DOPE pep-
tide-lipid [1]. In contrast, almost no DOPE was gen-
erated by incubation of proteinase K with MeO-suc-
AAPV-DOPE (unpublished data). The improved se-
lectivity of MeO-suc-AAPV-DOPE cleavage in-
creases the likelihood that liposomes containing this
peptide-lipid will be activated to fuse speci¢cally by
elastase.
The concentration of elastase used for most of the
experiments in this study (12.5 Wg elastase/ml = 0.42
WM) is threefold less than the amount of active elas-
tase found, for example, in the epithelial lining £uid
of children with cystic ¢brosis [28] and is 15^20 times
less than that found in adults with cystic ¢brosis [9].
Our preliminary experiments have shown that the
contents of granules isolated from human neutro-
phils were also capable of cleaving MeO-suc-
AAPV-DOPE to DOPE (unpublished data). The
minimum number of neutrophils required to provide
crude neutrophil granule proteins capable of cleaving
MeO-suc-AAPV-DOPE to DOPE was also less than
the number of neutrophils reported in 20 Wl of cystic
¢brosis epithelial lining £uid [28]. These results sug-
gest the amount of elastase required to activate DO-
DAP/MeO-suc-AAPV-DOPE liposomes may not be
a limiting factor for the use of these liposomes in
vivo.
In our previous studies liposomes were formulated
with the permanently cationic lipid, DOTAP [1]. In-
cluding a cationic lipid in the liposomal formulation
is intended to promote closer interaction between
liposomal and negatively charged cellular membranes
after the initial binding. Preparation of liposomes
with a cationic lipid and MeO-suc-AAPV-DOPE in
equimolar amounts creates a charge balanced lipo-
some that converts to an overall positive charge after
enzyme cleavage. This is due to conversion of the
negatively charged MeO-suc-AAPV-DOPE to the
zwitterionic DOPE after elastase cleavage. Enhanced
binding of elastase activated DODAP/Me-suc-
AAPV-DOPE (1:1) liposomes to both HL60 and
ECV304 cells was observed (Figs. 3^5 and 8), sug-
gesting the charge conversion was capable of pro-
moting binding. The increased binding was not due
to bridging between liposomes and cells by the pos-
itively charged elastase, as heat inactivated elastase
did not mediate the increase in binding (Fig. 5A).
DODAP was chosen as the cationic lipid in the
current studies for several reasons. The structure of
DODAP di¡ers from DOTAP only in the presence
of a tertiary amine instead of a quaternary amine.
This structural di¡erence translates to maximal pro-
BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126124
tonation at pH 5 and 20% positive charge at pH 7.4
[29]. The pH dependence of DODAP/Me-suc-AAPV-
DOPE liposomal binding/lipid mixing with HL60
cells (Fig. 4) supports the role of DODAP in liposo-
mal binding and indicates these liposomes are capa-
ble of binding in the low pH environment of the
endosome.
Because elastase is positively charged at pH 7.4,
MeO-suc-AAPV-DOPE in liposomes containing
50% DOTAP was not cleaved (unpublished data),
whereas the peptide-lipid was readily cleaved to
DOPE in DODAP/MeO-suc-AAPV-DOPE lipo-
somes (Fig. 2). Therefore, DODAP confers an ad-
vantage in enzymatic activity. The loss of negative
charge on the liposomal surface as cleavage proceeds
may partially explain the limited cleavage obtained
after a 2 h incubation, i.e. elastase is less e⁄ciently
bound to the surface of liposomes that have been
digested extensively.
Another advantage of DODAP is that a larger
change in surface charge is ultimately possible with-
out including so much positively charged lipid that
liposome destabilization occurs or non-speci¢c inter-
action with cells occurs before enzymatic cleavage or
endocytosis. The ultimate change in net charge is
from approximately 40% net negative surface charge
to approximately 15% net positive surface charge
under the conditions of our experiments. DODAP
may also limit the non-speci¢c association of these
liposomes with negatively charged cell membranes
until after endocytosis. In contrast, DOTAP is a po-
tent binding agent at physiological pH [32]. Finally,
the net negative charge of liposomes composed of
DODAP and MeO-suc-AAPV-DOPE at physiologi-
cal pH could limit liposomal aggregation and in-
crease in vivo circulation [33].
Elastase treatment of DODAP/Me-suc-AAPV-
DOPE liposomes triggered fusion between these lip-
osomes and HL60 cells at low pH (Fig. 7). Interest-
ingly, there was no uptake of £uorescent dextran
within these cells when incubated with elastase
treated, freeze-thawed liposomes and the accompany-
ing free TMR-dextran. This suggests the fusion of
DODAP/Me-suc-AAPV-DOPE liposomes with cells
is a non-leaky event. If not, we would have expected
to observe TMR-dextran within HL60 cells, due to
entry of free dextran through the liposome-cell fusion
contacts.
While elastase activated calcein delivery into live
ECV304 cells was clearly demonstrated (Fig. 10), the
mechanism of delivery is not yet certain. Possibilities
include uptake of free calcein across the cellular plas-
ma membrane prior to endocytosis, leakage of cal-
cein from liposomes into the endosomal compart-
ment followed by either transport across or
disruption of the endosomal membrane, or fusion
between liposomal and cellular membranes and de-
livery of encapsulated calcein into the cell cytoplasm.
The £uorescence dequenching of calcein encapsu-
lated within DODAP/Me-suc-AAPV-DOPE lipo-
somes remained unchanged after elastase treatment
as well as at pH 5 (unpublished data), indicating
these liposomes were stable under conditions mim-
icking the endosomal environment. However, contact
with the endosomal membrane or exchange of cellu-
lar proteins into the liposome could alter the stability
of the liposomes within endosomes. Notably, unac-
tivated liposomes did not exhibit signi¢cant calcein
delivery (Figs. 9 and 10) despite binding and uptake
into cells. It appears the elastase activated liposomes
are capable of further actions that permit calcein to
reach the cytoplasm, consistent with the much larger
calcein dequenching observed for elastase activated
liposomes (Fig. 9). Transport of free calcein directly
across the plasma membrane appears unlikely, as
calcein released from freeze-thawed DODAP/Me-
suc-AAPV-DOPE liposomes did not result in any
calcein within the cell despite the release of nearly
all of the encapsulated calcein (unpublished data).
Non-speci¢c di¡usion of leaked calcein across the
endosomal membrane remains a possible route of
entry. However, it is expected that both elastase
treated and untreated liposomes may exhibit this be-
havior. This was clearly not the case (Figs. 9 and 10).
Although we are unable to distinguish between endo-
somal disruption and fusion as the primary entry
mechanism, either is su⁄cient for the purpose of lip-
osome mediated delivery.
The successful transfer of aqueous contents probes
into adherent cells by elastase activation of DODAP/
MeO-suc-AAPV-DOPE liposomes suggests that such
systems may have great utility for both drug and
gene delivery once appropriate modi¢cations are
made to maximize serum stability and minimize po-
tential serum interference with binding and fusion.
Coupling selective enzyme triggering with targeting
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ligands may increase the likelihood of generating lip-
osomes that are stable until localized to the site of
interest. E¡orts are also under way to encapsulate
DNA within enzyme triggerable liposomes for selec-
tive transfection and gene expression.
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